The combination of NK and CD8+ T cells with CCL20/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The combination of NK and CD8+ T cells with CCL20/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells

Published:2017-08 Issue: Volume:318 Page:35-41
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Ye Jun-feng,Qi Wen-xi,Liu Ming-yuan,Li Yang

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Jilin Province Postdoctoral Science Foundation

Natural Science Foundation of Jilin Province

Publisher

Elsevier BV

Subject

Immunology

Reference26 articles.

1. Exploiting the curative potential of adoptive T-cell therapy for cancer;Hinrichs;Immunol. Rev.,2014

2. Adoptive immunotherapy for cancer: building on success;Gattinoni;Nat. Rev. Immunol.,2006

3. Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies;Schmeel;Int. J. Mol. Sci.,2014

4. Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model;Yang;PLoS One,2012

5. Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells;Ye;Int. Immunopharmacol.,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02

2. Nano based-oncolytic viruses for cancer therapy;Critical Reviews in Oncology/Hematology;2023-05

3. Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor;Vaccines;2023-02-09

4. Combining oncolytic viruses with immune cell therapy as treatments for cancer: OV, CAR T-cell, and NK combinations;NK Cells in Cancer Immunotherapy: Successes and Challenges;2023

5. Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity;Cells;2022-10-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3